Alps Group Inc

Alps Group Inc (NASDAQ:ALPS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors ALPS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

• Alps Group Launches Patient-Derived Organoid Program for Personalized Cancer Care (2026-06-23)
• Alps Group Launches Organoid Program, Aims for Malaysia's First Clinically Validated Platform (2026-06-23)
• Alps Group Subsidiary MyGenome Achieves Key Whole Genome Sequencing Accreditation (2026-06-09)
• Alps Group Subsidiary MyGenome Achieves Key Whole Genome Sequencing Accreditation, Expanding Market Access (2026-06-09)
• Alps Group receives Nasdaq delisting warning for sub-$1.00 bid price (2026-05-19)

Insider Transactions

ALPS files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.